Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Gerlach

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Cells|December 5, 2020
Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson's DiseaseSarah Plum, Britta Eggers, Stefan Helling, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 2, 2022
Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson's diseaseEva Gschmack, Camelia-Maria Monoranu, Hecham Marouf, et al.
Journal of Neurochemistry|September 2, 2005
Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cellsJie Li, Carsten Scheller, Eleni Koutsilieri, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 26, 2011
Influence of a genetic variant of the neuronal growth associated protein Stathmin 1 on cognitive and affective control processes: an event-related potential studyAnn-Christine Ehlis, Katharina Bauernschmitt, Thomas Dresler, et al.
Expert Opinion on Drug Safety|May 19, 2020
Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic reviewSanne M Kloosterboer, Denise Vierhout, Jana Stojanova, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 30, 2020
Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient careKarin Egberts, Su-Yin Reuter-Dang, Stefanie Fekete, et al.
Frontiers in Psychiatry|May 2, 2022
Responsivity of the Striatal Dopamine System to Methylphenidate-A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity DisorderHans-Christoph Aster, Marcel Romanos, Susanne Walitza, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 7, 2014
Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorderRegina Taurines, Monica Segura, Martin Schecklmann, et al.
Attention Deficit and Hyperactivity Disorders|April 13, 2013
No cross-sectional and longitudinal association of ferritin and symptoms of attention-deficit-/hyperactivity disorder in a large population-based sample of children: results from the GINIplus and LISAplus studiesMarcel Romanos, Carla M T Tiesler, Sibylle Koletzko, et al.
The Journal of Clinical Psychiatry|July 20, 2023
Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor OccupancyKatja Wesner, Christoph Hiemke, Niels Bergemann, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Cells|December 5, 2020
Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson's DiseaseSarah Plum, Britta Eggers, Stefan Helling, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 2, 2022
Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson's diseaseEva Gschmack, Camelia-Maria Monoranu, Hecham Marouf, et al.
Journal of Neurochemistry|September 2, 2005
Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cellsJie Li, Carsten Scheller, Eleni Koutsilieri, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 26, 2011
Influence of a genetic variant of the neuronal growth associated protein Stathmin 1 on cognitive and affective control processes: an event-related potential studyAnn-Christine Ehlis, Katharina Bauernschmitt, Thomas Dresler, et al.
Expert Opinion on Drug Safety|May 19, 2020
Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic reviewSanne M Kloosterboer, Denise Vierhout, Jana Stojanova, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 30, 2020
Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient careKarin Egberts, Su-Yin Reuter-Dang, Stefanie Fekete, et al.
Frontiers in Psychiatry|May 2, 2022
Responsivity of the Striatal Dopamine System to Methylphenidate-A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity DisorderHans-Christoph Aster, Marcel Romanos, Susanne Walitza, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 7, 2014
Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorderRegina Taurines, Monica Segura, Martin Schecklmann, et al.
Attention Deficit and Hyperactivity Disorders|April 13, 2013
No cross-sectional and longitudinal association of ferritin and symptoms of attention-deficit-/hyperactivity disorder in a large population-based sample of children: results from the GINIplus and LISAplus studiesMarcel Romanos, Carla M T Tiesler, Sibylle Koletzko, et al.
The Journal of Clinical Psychiatry|July 20, 2023
Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor OccupancyKatja Wesner, Christoph Hiemke, Niels Bergemann, et al.
Pageof 15